Paliperidone palmitate

This classification denotes a serotonin antagonist and dopamine antagonist and antipsychotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R8P8USM8FR. European Medicines Agency schedules Paliperidone palmitate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31687. Paliperidone palmitate generally arises in the molecular formula C39H57FN4O4. The term 'paliperidone palmitate' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule paliperidone palmitate under HS 29349990 and SITC 51579. As of Q4 2014, PALIPERIDONE PALMITATE remains US FDA's Preferred Term for this commodity. Paliperidone palmitate bears US NLM identifiers UMLS ID C2719626 and NCI Concept Code C83917. SMILES: CCCCCCCCCCCCCCCC(=O)OC1CCCN2C1NC(C(C2=O)CCN3CCC(CC3)C4C5CCC(CC5ON4)F)C.